Endothelial-derived MIF contributes to pulmonary endothelial cell proliferation in human pulmonary arterial hypertension

Morane Le Hiress (Le Plessis-Robinson, France), Morane Le Hiress, Ly Tu, Carole Phan, Raphaël Thuillet, Nicolas Ricard, Andrei Seferian, Elie Fadel, Gerald Simonneau, Alice Huertas, Yuichi Tamura, Marc Humbert, Christophe Guignabert

Source: International Congress 2015 – Pulmonary hypertension: promising small molecules
Session: Pulmonary hypertension: promising small molecules
Session type: Poster Discussion
Number: 4900
Disease area: Pulmonary vascular diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Morane Le Hiress (Le Plessis-Robinson, France), Morane Le Hiress, Ly Tu, Carole Phan, Raphaël Thuillet, Nicolas Ricard, Andrei Seferian, Elie Fadel, Gerald Simonneau, Alice Huertas, Yuichi Tamura, Marc Humbert, Christophe Guignabert. Endothelial-derived MIF contributes to pulmonary endothelial cell proliferation in human pulmonary arterial hypertension. Eur Respir J 2015; 46: Suppl. 59, 4900

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
MIF/CD74 contributes to the endothelial pro-inflammatory phenotype in pulmonary arterial hypertension
Source: Annual Congress 2013 –Pulmonary circulation: basic science
Year: 2013

Increased Cyr61 in pulmonary arterial hypertension involving in proliferation of pulmonary arterial smooth muscle cells
Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside
Year: 2016


MicroRNA-155 controls pulmonary artery fibroblast cell signalling and proliferation in a knockout mouse model: A role in pulmonary arterial hypertension
Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs
Year: 2014

Uric acid causes excessive pulmonary arterial smooth muscle cell proliferation via URATv1 upregulation in pulmonary arterial hypertension
Source: International Congress 2016 – The nature of pulmonary hypertension
Year: 2016

Inflammatory mediators contribute to pulmonary arterial cell dysfunction in a pulmonary arterial hypertension patient with BMPR2 mutation
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I
Year: 2013

Hypoxia-induced pulmonary artery fibroblast proliferation and migration is prevented by ASK1 inhibition in an in vitro cellular model of pulmonary hypertension
Source: International Congress 2015 – Pulmonary hypertension: novel insights into the biology of the disease
Year: 2015

Insulin-like growth factor-1 contributes to the pulmonary artery smooth muscle cell proliferation in pulmonary arterial hypertension
Source: International Congress 2014 – Pulmonary hypertension: pathobiology
Year: 2014

Endothelial cells in the pathogenesis of pulmonary arterial hypertension
Source: Eur Respir J, 58 (3) 2003957; 10.1183/13993003.03957-2020
Year: 2021



Targeting cell motility in pulmonary arterial hypertension
Source: Eur Respir J 2014; 43: 531-544
Year: 2013



Endothelial NO and its pathophysiologic regulation
Source: Annual Congress 2007 - Role of the endothelium in pulmonary function and disease
Year: 2007


Nuclear IL-33 arguments ST2 receptor expression in pulmonary arterial endothelial cells: Implication in the pathogenesis and progression of pulmonary arterial hypertension
Source: International Congress 2014 – Pulmonary hypertension: pathobiology
Year: 2014

Time-resolved study of endothelial shear-responsiveness in pulmonary arterial hypertension
Source: International Congress 2015 – Pulmonary hypertension: promising small molecules
Year: 2015

PDGF promotes pulmonary artery smooth muscle cell proliferation and migration in pulmonary arterial hypertension
Source: Annual Congress 2006 - Signalisation in the pulmonary vasculature: new pathways and wrong signals
Year: 2006


Dasatinib induces lung vascular toxicity and predisposes to pulmonary hypertension
Source: International Congress 2016 – Clinic of pulmonary hypertension
Year: 2016



Vascular remodelling is reversed following BMPR2 modified endothelial progenitor cell therapy in a MCT-induced PAH rat model
Source: International Congress 2016 – The nature of pulmonary hypertension
Year: 2016

Endothelial cell mechanics are altered in pulmonary arterial hypertension (PAH)
Source: Annual Congress 2011 - Experimental pulmonary hypertension
Year: 2011

Roles of circulating and resident myeloid cell subpopulations in bronchopulmonary remodeling and pulmonary hypertension
Source: Annual Congress 2013 –Pulmonary circulation: basic science
Year: 2013

Comparison of current therapies against endothelin-induced growth in pulmonary smooth arterial muscle cells (PASMCs) derived from patients with pulmonary arterial hypertension
Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs
Year: 2014


The transcription factor slug is increased in pulmonary artery endothelial cells of COPD patients
Source: Annual Congress 2013 –Pulmonary circulation: basic science
Year: 2013

Olfactory receptors in pulmonary arterial hypertension: A novel pathway of vascular remodeling?
Source: International Congress 2015 – Pulmonary hypertension: novel insights into the biology of the disease
Year: 2015